Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvectis Pharma (NVCT) Prepaid Assets (2021 - 2026)

Nuvectis Pharma has reported Prepaid Assets over the past 6 years, most recently at $268000.0 for Q1 2026.

  • Quarterly results put Prepaid Assets at $268000.0 for Q1 2026, down 5.63% from a year ago — trailing twelve months through Mar 2026 was $268000.0 (down 5.63% YoY), and the annual figure for FY2025 was $75000.0, up 1.35%.
  • Prepaid Assets reached $268000.0 in Q1 2026 per NVCT's latest filing, up from $75000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $1.2 million in Q3 2022 and bottomed at $59000.0 in Q4 2023.
  • Median Prepaid Assets over the past 5 years was $250000.0 (2024), compared with a mean of $364823.5.
  • The largest annual shift saw Prepaid Assets surged 352.75% in 2022 before it plummeted 85.68% in 2023.
  • Over 5 years, Prepaid Assets stood at $412000.0 in 2022, then tumbled by 85.68% to $59000.0 in 2023, then increased by 25.42% to $74000.0 in 2024, then rose by 1.35% to $75000.0 in 2025, then skyrocketed by 257.33% to $268000.0 in 2026.
  • Business Quant data shows Prepaid Assets for NVCT at $268000.0 in Q1 2026, $75000.0 in Q4 2025, and $145000.0 in Q3 2025.